Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interchangeability Study of Hulio vs Humira in Psoriasis
NCT05637515Phase 3Completed
- Sponsor
- Biocon
- Start
- Nov 2022
- Primary completion
- Sep 2023
- Modality
- Monoclonal Antibodies
- Countries
- 4
01
Overview
A Phase 3 trial of adalimumab in plaque psoriasis, sponsored by Biocon. Started Nov 2022; status: completed.
02
Drugs
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT05637515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05637515.